Abstract:Aims: To evaluate the effects of chimerism on the mice heart transplanted survival with the bone marrow infusion. Methods: Bone marrow cells (BMCs) were obtained from BALB/c mice. These BMCs were injected into the irradiated (2Gy-Co60) C57BL/6 mice through femoral vein. Then Group A mice were treated with Cyclosporine (1 mg/kg) for 21 days and Group B were not treated with Cyclosporine. Group C were treated as the control group without BMCs infusion. Group D were treated with Cyclosporine (1 mg/kg) for 21 days pre-hearttransplantation without BMCs infusion. After 21 days, the C57BL/6 mice received heart allografts from BALB/c. To determine the degree of chimerism in BMCs infusion recipients, peripheral blood were isolated on day 7, 14, 21. Allografts were harvested 10 days after heart transplantation for the histological analysis. Results: (1) Chimerism detected in the peripheral blood of Group A mice on day 7 after BMCs infusion was 6.1 +/- 2.5%, on day 14 was 15.4 +/- 2.9% and on day 21 was 10.7 +/- 2.6%. For the Group B mice on day 7 after BMCs infusion, the chimerism was 2.8 +/- 1.1%, on day 14 was 11.2 +/- 4.8% and on day 21 was 7.4 +/- 3.7%. For the Groups C and D mice, no chimerism was observed. Group A mice had the tendency toward improved level of chimerism than Group B mice. (2) The survival time of Group A (n = 6) was 13.0 +/- 1.4 days which was significantly longer than Group B (n = 6) with the survival time was 8.5 +/- 1.3 days (p<0.001), also longer than the mice in Groups C and D, the survival time of which were 10.0 +/- 1.3 days (p = 0.008) and 9.4 +/- 1.1 days (p = 0.004). There is no significant difference among Groups B, C, and D. (3) The HE staining showed the much more seriously heart rejection in Groups B, C and D than Group A. Conclusions: The chimerism was found in the BMCs infusion groups. Without the CsA treatment combined with chimerism could not protect the transplanted heart. There was no obvious evidence showed that the chimerism alone could improve the survival time of cardiac allografts in mice. Published by Elsevier B.V.

Bone marrow transplantation concurrently reconstitutes donor liver and immune system across host species barrier in mice.

Mouse Heterotopic Abdominal Heart Transplant Model

Transcriptomics Confirm the Establishment of a Liver-Immune Dual-Humanized Mouse Model after Transplantation of a Single Type of Human Bone Marrow Mesenchymal Stem Cell

[The Study on Immunomodulation of Donor Mesenchymal Stem Cells on Discordant Liver Xenotransplantation].

Effects of chimerism on the mice heart transplanted survival with the bone marrow infusion.

HBV Infection-Induced Liver Cirrhosis Development in Dual-Humanised Mice with Human Bone Mesenchymal Stem Cell Transplantation

Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis

A Murine Model of Hepatic Veno-occlusive Disease Induced by Allogeneic Hematopoietic Stem Cell Transplantation

Effect of Allogeneic Bone Marrow–derived Mesenchymal Stem Cells Transplantation in a Polyi:C-Induced Primary Biliary Cirrhosis Mouse Model

Survival Time of Cardiac Allografts Prolonged by Isogeneic BMT in Mice.

Mice Engrafted with Human Liver Cells

Establishment of a Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation Model in Mice and Its Related Study

Donor-derived Bone Marrow Transfusion Produces Mixed Chimerism and Promotes a Th2 Shift in Th1/Th2 Balance in Rat Heterotopic Small Bowel Transplantation

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

A novel inducible haematopoietic cell‐depleting mouse model for chimeric complementation of blood cells

Infusion of Nonmyeloablative Bone Marrow Alleviates Acute Rejection Reaction in Liver Allotransplantation

Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model

Successful Treatment of Murine Autoimmune Cholangitis by Parabiosis: Implications for Hematopoietic Therapy

Characterization of xenogeneic mouse-to-rat bone marrow chimeras. I. Examination of hematologic and immunologic function

Donor Specific Tolerance for MHC Mis-Matched Murine Skin Allograft Induced by Donor Bone Marrow Transplantation with Precondition of High Dose Immunosuppressants

[Establishment of Mouse Model with Humanized Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia].